Risperidone Tablets

Form: Tablets

Strength: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg

Reference Brands: Risperdal®(US & EU); EU: Risperidon-ratiopharm®, Rispolept®, Rispen® '

Category: Antipsychotropic Drugs

Risperidone tablets are approved in both the USA and EU for the treatment of schizophrenia, bipolar I disorder, and irritability associated with autistic disorder. In the US, the FDA regulates risperidone under NDA pathways, ensuring rigorous quality and efficacy standards. In the EU, risperidone is authorized through national procedures and mutual recognition among member states. Available in multiple strengths, these tablets offer tailored dosing options. Risperidone's classification as an atypical antipsychotic supports its broad clinical application. To explore more forms and global availability of Risperidone, visit Pharmatradz.com.